Clinical trials recruiting for Apathy in Dementia
3
Recruiting trials
0
US states with sites
2
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 2 1Not applicable 2
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Methylphenidate | 1 |
| Methylphenidate (MPH) | 1 |
Self-screener
Recruiting trials
- Combined Brain Stimulation and Methylphenidate Treatment for Apathy in Dementia
- Effects of Personalized Digital Reminiscence Therapy on Patients With Neurocognitive Disorders
- rTMS for Apathy Clinical Trial
Related conditions
Trials recruiting for Apathy in Dementia often also study these conditions. Each links to its own recruiting-trial list.
Apathy 10Alzheimer's disease 617Neurocognitive Disorders 11Mild cognitive impairment 96Depression Mild 5Depression 1463Dementia 106Cognitive Impairment, Mild 5Alzheimer Dementia (AD) 17Alzheimer Dementia 8
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Apathy in Dementia trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.